Sustained beneficial metabolic effects 18 months after a 30-day very low calorie diet in severely obese, insulin-treated patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 77, Issue 1, 2007, Pages 70-76

  Jazet, Ingrid M ^a   de Craen, Anton J ^a   van Schie, Eveline M ^a   Meinders, A Edo ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Glucose lowering diet; Type 2 diabetes; VLCD

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; ROSIGLITAZONE; SULFONYLUREA;

ADULT; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DIET THERAPY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; INSULIN TREATMENT; LIPID BLOOD LEVEL; LOW CALORY DIET; MALE; METABOLISM; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; WEIGHT GAIN;

BLOOD GLUCOSE; BLOOD PRESSURE; CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; OBESITY, MORBID;

EID: 34247154339     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.10.019     Document Type: Article

References (33)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diab. Care 27 (2004) 1047-1053
2. Prevalence of overweight and obesity among adults with diagnosed diabetes-United States, 1988-1994 and 1999-2002 MMWR Morb. Mortal Wkly Rep. 53, 2004, pp. 1066-1068.
3. Kahn S.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46 (2003) 3-19
4. Kelley D.E., Wing R., Buonocore C., Sturis J., Polonsky K., and Fitzsimmons M. Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 77 (1993) 1287-1293
5. Wing R.R., Blair E.H., Bononi P., Marcus M.D., Watanabe R., and Bergman R.N. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diab. Care 17 (1994) 30-36
6. Henry R.R., Scheaffer L., and Olefsky J.M. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 61 (1985) 917-925
7. Greco A.V., Mingrone G., Giancaterini A., Manco M., Cinti S., Granzotto M., et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51 (2002) 144-151
8. Petersen K.F., Dufour S., Befroy D., Lehrke M., Hendler R.E., and Shulman G.I. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54 (2005) 603-608
9. Jazet I.M., Pijl H., Frolich M., Schoemaker R.C., and Meinders A.E. Factors predicting the blood glucose lowering effect of a 30-day very low calorie diet in obese Type 2 diabetic patients. Diabet. Med. 22 (2005) 52-55
10. Jazet I.M., Pijl H., Frolich M., Romijn J.A., and Meinders A.E. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin. Metabolism 54 (2005) 705-712
11. B.L. Andersson, P. Bjorntorp, J.C. Seidell, Measuring obesity-classification and description of anthropometric data. Report on a WHO consultation on epidemiology of obesity, Copenhagen, Nutrition unit, WHO regional office for Europe; EUR/ICP/NUT. 125, 1988, pp. 1-22.
12. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
13. Stevens R.J., Kothari V., Adler A.I., and Stratton I.M. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin. Sci. (Lond.) 101 (2001) 671-679
14. Dhindsa P., Scott A.R., and Donnelly R. Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with Type 2 diabetes in secondary failure: outcomes after 1 year. Diabet. Med. 20 (2003) 319-324
15. Bauman W.A., Schwartz E., Rose H.G., Eisenstein H.N., and Johnson D.W. Early and long-term effects of acute caloric deprivation in obese diabetic patients. Am. J. Med. 85 (1988) 38-46
16. Guare J.C., Wing R.R., and Grant A. Comparison of obese NIDDM and nondiabetic women: short- and long-term weight loss. Obes. Res. 3 (1995) 329-335
17. Wing R.R., Marcus M.D., Salata R., Epstein L.H., Miaskoewicz S., and Blair E.H. Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch. Intern. Med. 151 (1991) 1334-1340
18. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38, UK Prospective Diabetes Study Group BMJ 317, 1998, 703-713.
19. Hansson L., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351 (1998) 1755-1762
20. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diab. Care 16 (1993) 434-444
21. Colhoun H.M., Betteridge D.J., Durrington P.N., Hitman G.A., Neil H.A., and Livingstone S.J. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364 (2004) 685-696
22. Collins R., Armitage J., Parish S., Sleigh P., and Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361 (2003) 2005-2016
23. Sever P.S., Poulter N.R., Dahlof B., Wedel H., Collins R., Beevers G., et al. Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-lipid-lowering arm (ASCOT-LLA). Diab. Care 28 (2005) 1151-1157
24. Manninen V., Elo M.O., Frick M.H., Haapa K., Heinonen O.P., Helo P., et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 260 (1988) 641-651
25. Rubins H.B., Robins S.J., Collins D., Fye C.L., Anderson J.W., Elam M.B., et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N. Engl. J. Med. 341 (1999) 410-418
26. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 357 (2001) 905-910
27. Standards of medical care in diabetes. Diab. Care 27 Suppl. 1 (2004) S15-S35
28. Williams K.V., Mullen M.L., Kelley D.E., and Wing R.R. The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diab. Care 21 (1998) 2-8
29. Wing R.R., Blair E., Marcus M., Epstein L.H., and Harvey J. Year-long weight loss treatment for obese patients with type II diabetes: does including an intermittent very-low-calorie diet improve outcome?. Am. J. Med. 97 (1994) 354-362
30. Muscelli E., Mingrone G., Camastra S., Manco M., Pereira J.A., Pareja J.C., et al. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am. J. Med. 118 (2005) 51-57
31. Greenway S.E., Greenway III F.L., and Klein S. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch. Surg. 137 (2002) 1109-1117
32. Amatruda J.M., Richeson J.F., Welle S.L., Brodows R.G., and Lockwood D.H. The safety and efficacy of a controlled low-energy ('very-low-calorie') diet in the treatment of non-insulin-dependent diabetes and obesity. Arch. Intern. Med. 148 (1988) 873-877
33. Anderson J.W., Brinkman-Kaplan V.L., Lee H., and Wood C.L. Relationship of weight loss to cardiovascular risk factors in morbidly obese individuals. J. Am. Coll. Nutr. 13 (1994) 256-261